Immunosuppressive role of transforming growth factor beta in breast cancer

Publisher： Elsevier

ISSN： 1529-1049

Source： Clinical and Applied Immunology Reviews, Vol.3, Iss.6, 2003-05, pp. : 277-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Transforming growth factor-beta: A target for cancer therapy

By Kelly Ronan J. Morris John C.

Journal of Immunotoxicology, Vol. 7, Iss. 1, 2010-03 ,pp. : 15-26

Informa Healthcare

Access to resources Recommend Favorite

Transforming Growth Factor-beta

By Cox D.A. Maurer T.

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 25-30

Academic Press

Access to resources Recommend Favorite

Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients

By Pozzetto U. Citterio F. Romagnoli J. Scata M.C. Nanni G. Castagneto M.

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1740-1742

Elsevier

Access to resources Recommend Favorite

Role of Transforming Growth Factor Beta in Corneal Function, Biology and Pathology

Current Molecular Medicine, Vol. 10, Iss. 6, 2010-08 ,pp. : 565-578

Bentham Science Publishers

Access to resources Recommend Favorite

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients

By Honegger A. Hofer E. Barañao R. Mackinlay T. Mackinlay D. Bullorsky E. Bordenave R. Chasseing N.

Annals of Hematology, Vol. 81, Iss. 2, 2002-02 ,pp. : 80-85

Springer Publishing Company

Access to resources Recommend Favorite